Skip to main content
Article thumbnail
Location of Repository

The Role of Heparin in Thromboembolic Complications Following Carotid Endarterectomy

By Gregory Scott McMahon

Abstract

The importance of platelets emerged from a local research programme, which aimed to reduce the stroke risk associated with carotid endarterectomy (CEA). It had been demonstrated that intra-operative heparinisation induced a transient reversal of aspirin inhibition; platelets were able to aggregate in response to arachidonic acid (AA).\ud It was hypothesized that intra-operative anticoagulation with intravenous low molecular weight heparin (LMWH) instead of unfractionated heparin (UFH) might be associated with a reduction in pleiotropic platelet effects, and that this would result in a reduction of post-CEA embolization, a surrogate marker for stroke risk.\ud A randomized controlled trial recruited 183 patients; 91 randomized to receive standard intra-operative anticoagulation with 5000IU UFH, and; 92 who received 2500IU LMWH intravenously. Studies conducted in sub-populations aimed to investigate the platelet aggregatory responses to AA and adenosine diphosphate (ADP) and the platelet pathways that were active (plasma and serum were assayed for the stable products of platelet metabolism; thromboxane (TXB2) from the cyclo-oxygenase-1 (COX-1) pathway and 12- hydroxyeicosatretraenoic acid (12-HETE) from the 12-lipoxygenase (12-LOX) pathway).\ud To determine how heparin might interact with the platelet, lipase activity, the presence of heparin antibodies and anti-factorXa (FXa) activity were studied.\ud Increases in platelet aggregation to AA and ADP were observed 3 minutes after heparinisation. In response to AA, these increases were similar for both UFH and LMWH, but patients who received UFH demonstrated significantly greater aggregation in response to ADP. Whilst there was no increase in the production of TXB2, there was a significant increase in the generation of 12-HETE. The increase in platelet response was associated with anti-FXa activity, but not with lipase or heparin antibody activity. The intra-operative substitution of LMWH for UFH was associated with a significant reduction in the risk of patients experiencing high-rate embolization post-operatively, and there is an argument for the re-evaluation of anticoagulation during CEA

Publisher: University of Leicester
Year: 2011
OAI identifier: oai:lra.le.ac.uk:2381/9638

Suggested articles

Citations

  1. (1983). 1009 consecutive carotid endarterectomies using local anesthesia, EEG and selective shunting with Pruitt-Inahara carotid shunt. Contemp Surg.
  2. 12(S)-Hydroperoxyeicosatetraenoic acid increases arachidonic acid availability in collagenprimed platelets.
  3. (1991). 12Shydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation.
  4. (2001). A cell-based model of hemostasis. Thromb Haemost.
  5. (1998). A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
  6. (1996). A comparison of quality control methods applied to carotid endarterectomy. Eur J Vasc Endovasc Surg.
  7. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis.
  8. (1994). A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol.
  9. (1992). A definition of the intima of human arteries and of its atherosclerotisis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation.
  10. (2001). A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost.
  11. (1999). A policy of quality control assessment reduces the risk of intra-operative stroke during carotid endarterectomy. Eur J Vasc Endovasc Surg.
  12. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V.
  13. Abolishment of alimentary lipemia following injection of heparin.
  14. Acetylation of prostaglandin synthase by aspirin.
  15. Acid hydrolase secretion. In: Platelet responses and metabolism II. Boca Raton:
  16. Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces.
  17. Activation of human factor V by factor Xa and thrombin.
  18. Acute carotid occlusion: Indication for surgery?
  19. An update on aspirin in the primary prevention of cardiovascular disease.
  20. Anti-platelet effect of aspirin is substantially reduced after administration of heparin during carotid endarterectomy.
  21. (1980). Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. Thromb Res.
  22. Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunction.
  23. Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy.
  24. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients.
  25. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients.
  26. Appropriateness of carotid endarterectomy.
  27. (2005). Are some strokes preventable? The potential role of transcranial doppler in transient ischaemic attacks of carotid origin. Lancet Neurol.
  28. Arterial embolism occurring during systemic heparin therapy.
  29. Aspirin and clopidogrel: efficacy, safety and the issue of drug resistance. Arterioscler Thromb Vasc Biol.
  30. Aspirin as an antiplatelet drug.
  31. Aspirin resistance: definition, mechanisms and clinical read-outs. Thromb Haemost.
  32. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke or cardiovascular death in patients at high risk for cardiovascular events.
  33. (2008). Aspirin: Promise and resistance in the new millenium. Arterioscler Thromb Vasc Biol.
  34. (1976). Assay of heparin in plasma using a chromogenic substrate. Thromb Res.
  35. Atherosclerotic plaque development.
  36. (1974). Axillo-mesenteric bypass for acute mesenteric infarction. Vascular Surgery.
  37. Bacillus pasteurii urease shares with plant ureases the ability to induce aggregation of blood platelets.
  38. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
  39. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.
  40. (1993). Biphasic effects of low molecular weight and conventional heparins on chylomicron clearance in rats. Arterioscler Throm.
  41. (2009). Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention. Thromb Haemost.
  42. (1983). Carotid bifurcation atherosclerosis: Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res.
  43. Carotid endarterectomy - an expression of concern.
  44. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis.
  45. Carotid endarterectomy in patients with transient cerebral ischaemia.
  46. Carotid endarterectomy studies: a glimmering of science.
  47. Carotid endarterectomy with local anesthesia: results and advantages.
  48. Carotid endarterectomy with trans-cranial Doppler and electroencephalographic monitoring: A prospective study in 130 operations.
  49. Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
  50. Carotid endarterectomy: does it work?
  51. (1996). Carotid endarterectomy: lessons from intraoperative monitoring - a decade of experience. Ann Surg.
  52. (1990). Carotid plaque morphology and risk for stroke.
  53. (1998). Cerebral microembolism and ischemic changes associated with carotid endarterectomy.
  54. Clinical relevance of intraoperative embolization detected by transcranial Doppler ultrasonography during carotid endarterectomy: a prospective study of 100 patients.
  55. Cloning of the cDNA and genes for the hamster and human â2-adrenergic receptors.
  56. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.
  57. Coagulation and atherothrombotic disease.
  58. Collaborative Group. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial.
  59. Collagem polymorphism in the normal and diseased blood vessel wall: Investigation of collagen types I, III
  60. Collagen synthesis by bovine aortic endothelial cells in culture.
  61. (2000). Comparative pharmacokinetics of LMWHs. Semin Thromb Hemost.
  62. Compensatory enlargement of human atherosclerotic coronary arteries.
  63. (1998). Consensus on microembolus detection by TCD.
  64. Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT).
  65. (2001). Contribution of platelet-derived factor Va to thrombin generation on immobilized collagenand fibrinogen-adherent platelets. Thromb Haemost.
  66. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.
  67. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin
  68. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia.
  69. Cost of stroke in Australia from a societal perspective. Results from the North East Melbourne Stroke Incidence Study (NEMESIS).
  70. Criteria for immediate reoperation following carotid surgery.
  71. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
  72. (1994). Development of aspirin resistance in persons with previous ischemic stroke.
  73. Development of platelet secretory granules.
  74. (1995). Diagnosis, treatment and pathophsiology of autoimmune thrombocytopenias. Crit Rev Oncol Hematol.
  75. (1997). Differential effect of a low-molecular weight heparin (dalteparin) and unfractionated heparin on platrelet interaction with the subendothelium under flow conditions. Thromb Res.
  76. Dipyridamole inhibition of adenosine metabolism in human blood.
  77. Dual antiplatelet therapy prior to carotid endarterectomy reduces postoperative embolisation and thromboembolic events: post-operative transcranial Doppler monitoring is now unnecessary.
  78. Dual role of tubulin-cytoskeleton in store-operated calcium entry in human platelets.
  79. (1987). Effect of heparin and contrast medium on platelet function during routine cardiac catheterisation. Cardiovasc Res.
  80. Effect of heparin and heparin fractions on platelet aggregation.
  81. (1993). Effect of heparin and low molecular weight heparin on platelets. Seminars in Thrombosis and Hemostasis.
  82. Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial).
  83. Effects of 12-HETE on isolated dog renal arcuate arteries.
  84. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
  85. (1975). Effects of ticlopidine, a new platelet aggregation inhibitor in man. Clin Pharmacol Ther.
  86. (1994). Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo". Thromb Haemost.
  87. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment.
  88. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group.
  89. Elastase secretion by stimulated macrophages: Characterization and regulation.
  90. Endothelial cell receptors for histamine.
  91. Endothelial mitosis around aortic branches in normal guinea pigs.
  92. (1998). Epidemiology of carotid endarterectomy among Medicare beneficiaries: 1985-1996 update.
  93. (1994). Equivalence of measurements of carotid stenosis: a comparison of three methods on 1001 angiograms: European Carotid Surgery Trialists' Collaborative Group.
  94. European stroke prevention study II. Dipyridamole and acetylsalicyclic acid in the secondary prevention of stroke.
  95. (1977). Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin III. Thromb Res.
  96. Evidence for a second type of fibril branch point in fibrin polymer networks, the trimonlecular junction.
  97. (1989). Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Atherosclerosis.
  98. Fibrin assembly: lateral aggregation and the role of the two pairs of fibrinopeptides.
  99. Final report on the aspirin component of the ongoing physician's health study.
  100. Five year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study.
  101. for NASCET. Further comments on the measurement of carotid stenosis from angiograms.
  102. for the Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis.
  103. (1997). for the International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological subtypes. Results from an International Collaboration.
  104. From Hippocrates to PalmazSchatz, The History of Carotid Surgery.
  105. Functional consequences of integrin gene mutations in mice. Circ Res.
  106. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.
  107. (1996). Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low molecular weight heparin.
  108. Heparin and low-molecular-weight heparin:
  109. Heparin binding to resting and activated platelets.
  110. Heparin effects on plasma lysolecithin formation and platelet aggregation.
  111. Heparin in surgical treatment of blood vessels.
  112. (1973). Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet.
  113. Heparin modulates integrin function in human platelets.
  114. (1998). Heparin-induced thrombocytopenia: mew insights into the impact of the FcãRIIA-R-H131 polymorphism.
  115. Heterologous supersensitization between serotonin2 and á2-adrenergic receptor-mediated intracellular calcium mobilization in human platelets.
  116. High embolic rate early after carotid endarterectomy is associated with early cerebrovascular complications, especially in women.
  117. How the macrophage regulates its extracellular environment.
  118. (1995). Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface.
  119. Identification of the platelet ADP receptor targeted by antithrombotic drugs.
  120. (1999). Immediate reoperation for perioperative stroke after 2250 carotid endarterectomies: Differences between intraoperative and early postoperative stroke. J Vasc Surg.
  121. Increased levels of 12(S)-HETE in patients with essential hypertension.
  122. (1998). Increased platelet responsiveness following IX - References coronary stenting: heparin as a possible aetiological factor in stent thrombosis.
  123. (1994). Induction of inflammatory mediator release (12-hydroxyeicosatetraenoic acid) from human platelets by pseudomonas aeruginosa. Int Arch Allergy Immunol.
  124. (1998). Inhibition of platelet function by recombinant soluble ectoADPase/CD39.
  125. Insights into the pathogenesis of acute ischemic syndromes.
  126. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets: A checkpoint for translational control.
  127. Interaction of platelet membrane systems in blood platelets.
  128. Interactions of insulin and insulin-like growth factors (IGF) with endothelial cells.
  129. Internal carotid artery back pressure, intraoperative shunting, ulcerated atheromata, and the incidence of stroke during carotid endarterectomy.
  130. International comparison of stroke cost studies.
  131. (1968). International trends in mortality from stroke,
  132. (1995). Inversion of lipase stereospecificity for fluorogenic alkyldiacyl glycerols. Effect of substrate solubilization.
  133. (1989). Isolation and characterisation of human blood platelet mRNA and construction of a cDNA library in lamda gt11. Confirmation of the platelet derivation by identification of GPIb coding mRNA and cloning of a GPIb coding cDNA insert. Thromb Haemost.
  134. (1992). Isolation and characterization of heparin sulfate proteoglycans produced by cloned rat microvascular endothelial cells.
  135. IX - References
  136. Joint study of extracranial arterial occlusion, V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischaemic attacks and cervical carotid artery lesions.
  137. (1970). Kinetics of cellular proliferation in experimental atherosclerosis: Radioautography with grain counts in cholesterol-fed rabbits. Arch Pathol.
  138. Lack of early augmentation of platelet reactivity after coronary intervention in patients treated with bivalirudin.
  139. (1996). Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.
  140. (1988). Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low-molecular weight heparin fragment (Fragmin). Acta Med Scand Suppl.
  141. (1988). Lipoprotein receptors and endothelial cells. Semin Thromb Hemost.
  142. (1975). Lipoprotein uptake by cultured human arterial smooth muscle cells. Biochim Biophys Acta.
  143. Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes.
  144. Localiztion of cyclo-oxygenase and thromboxane synthetase in human platelet intracellular membranes.
  145. (1997). Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation.
  146. Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme.
  147. macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children.
  148. Making carotid surgery safer.
  149. (1982). Management of postendarterectomy neurologic deficits. Arch Surg.
  150. (1983). Mechanism of action of dipyridamole. Thromb Res Suppl.
  151. Mechanisms of intracerebral hemorrhage after carotid endarterectomy.
  152. (1991). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptro activation.
  153. Monitoring and cerebral protection during carotid endarterectomy.
  154. Monitoring middle cerebral artery blood velocity during carotid endarterectomy.
  155. (1998). Monitoring of brain function during carotid endarterectomy: an analysis of contemporary methods.
  156. Mortality by cause for eight regions of the world: global burden of disease study.
  157. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.
  158. Neuromonitoring during surgery.
  159. (1996). New fluorogenic triacyclglycerol analogs as substrates for the determination and chiral discrimination of lipase activities.
  160. Noninvasive transcranial Doppler ultrasound recording of flow velocity in the basal cerebral arteries.
  161. on behalf of the MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.
  162. (1976). on behalf of the participants in the WHO Collaborative Study on the Control of Stroke in the Community. Experience from a mulitcentre stroke register: a preliminary report. Bull World Health Organ.
  163. on behalf of the Swedish Enoxa Study Group. Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial.
  164. Outcome of surgical treatment of 110 patients with transient ischemic attack.
  165. Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis.
  166. Patients' thromboembolic potential after carotid endarterectomy is related to the platelets' sensitivity to adenosine diphosphate.
  167. (2001). Patients' thromboembolic potential between bilateral carotid endarterectomies remains stable over time. Eur J Vasc Endovasc Surg.
  168. Perioperative stroke after carotid endarterectomy: Etiological risk factors and management.
  169. (1985). Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist. J Pharmacol Exp Ther.
  170. Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitor. Cardiovascular drug reviews.
  171. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.
  172. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina.
  173. (1987). Platelet activation by plasma lipoproteins. Prog Cardiovasc Dis.
  174. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors.
  175. (1998). Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.
  176. Platelet aggregation following heparin and protamine administration.
  177. Platelet aggregation.
  178. (1993). Platelet alpha-granules. Blood Reviews.
  179. (1999). Platelet dense granules: structure, function and implications for haemostasis. Thromb Res.
  180. (1992). Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost.
  181. Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjects.
  182. (2004). Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance? Thromb Haemost.
  183. Platelet inositol lipid metabolism and calcium flux.
  184. (1988). Platelet lipoprotein interactions. Semin Thromb Hemost.
  185. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimietic-induced intracellular calcium mobilization and platelet aggregation.
  186. Platelet morphology, aggregation and secretion.
  187. Platelet receptors.
  188. Platelet structure.
  189. Platelet-collagen interactions: membrane receptors and intracellular signalling pathways.
  190. (1998). Plateletderived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation.
  191. Platelets and anti-platelet therapy.
  192. (1994). Population variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy. Arch Pathol Lab Med.
  193. Possible involvement of protein-tyrosine kinases such as p72SYK in the discsphere change response of porcine platelets.
  194. (1996). Predictive value of carotid artery stump pressure during carotid endarterectomy. Neurosurg Clin NA.
  195. Prevalence of stroke and stroke-related disability: estimates from the Auckland Stroke Studies.
  196. Preventable stroke and stroke prevention.
  197. (1997). Prevention of postoperative thrombotic stroke after carotid endarterectomy: the role of transcranial Doppler ultrasound. J Vasc Surg.
  198. Profile and prevalence of aspirin resistance in patients with cardiovascular disease.
  199. Progress in the understanding of the protein C anticoagulant pathway.
  200. Prostaglandin endoperoxides: novel transformations of arachidonic acid in human platelets.
  201. (1978). Prostaglandins and thromboxanes. Ann Rev Biochem.
  202. (1988). Protein C and the endothelium. Semin Thromb Hemost.
  203. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
  204. (1995). Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons. Arch Biochem Biophys.
  205. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.
  206. (1988). Qunatification in vivo of increased LDL content and rate of LDL degradation in normal rabbit aorta occurring at sites susceptible to early atherosclerotic lesions. Circ Res.
  207. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).
  208. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia.
  209. Reducing the risk of carotid surgery: A 7-year audit of the role of monitoring and quality control assessment.
  210. Relation between middle cerebral artery blood flow velocity and stump pressure during carotid endarterectomy.
  211. Review of community hospital experience with carotid endarterectomy.
  212. (1993). Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart
  213. Role of completion angioscopy in detecting technical error after caortid endarterectomy.
  214. Role of glutathione peroxidase and hexose monophosphate shunt in the platelet lipoxygenase pathway.
  215. Role of heparin sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes.
  216. (1986). Role of lipoxygenase metabolism in platelet function: Effect of aspirin and salicylate. Prostaglandins Leukotrienes Med.
  217. (1996). Role of pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes). Infect Immun.
  218. (1994). Role of the alpha C domains of fibrin in clot formation.
  219. Scientific and therapeutic advances in antiplatelet therapy.
  220. Secretion of a specific collagenase by stimulated macrophages.
  221. Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study.
  222. Selective inhibition of platelet lipoxygenase by baicalein.
  223. Serotonin and the vascular wall.
  224. (1999). Signalling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. Thromb Haemost.
  225. Site and pathogenesis of infarcts associated with carotid endarterectomy.
  226. ß2 integrin modulates platelet caspase activation and lifespan in mice.
  227. Stroke and mortality rate in carotid endarterectomy: 228 consecutive operations.
  228. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.
  229. (2001). Stroke from carotid endarterectomy: when and how to reduce perioperative stroke rate? Eur J Vasc Endovasc Surg.
  230. (1973). Studies of protein passage through arterial endothelium: III. Effect of blood pressure levels on the passage of fine structural protein tracers through rat arterial endothelium. Lab Invest.
  231. (1973). Studies on protein passage through arterial endothelium: II. Regional differences in permeability to fine structural protein tracers in arterial endothelium of normotensive rat. Lab Invest.
  232. Study of Infarct Survival Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected myocardial infarction:
  233. Stump pressure and transcranial Doppler for predicting shunting in carotid endarterectomy.
  234. Stump pressure, electroencephalographic changes, and the contralateral carotid artery: another look at selective shunting.
  235. Successful carotid endarterectomy for cerebrovascular insufficiency: nineteen year follow-up.
  236. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin.
  237. Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis.
  238. (1998). Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST).
  239. (1959). Surgical considerations of occlusive disease of innominate, carotid, subclavian and vertebral arteries. Ann Surg.
  240. Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis.
  241. (1998). Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.
  242. (1979). Synthesis of connective tissue macromolecules by smooth muscle. Int Rev Connect Tissue Res.
  243. Synthesis of prostalandin I2 (prostacyclin) by cultured human and bovine endothelial cells.
  244. Ten-year survival after first-ever stroke in the Perth Community Stroke Study.
  245. The active site of thrombin is altered upon binding to thrombomodulin.
  246. (1994). The antiaggregating activity by clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A. Thromb Haemost.
  247. (1994). The cause of peri-operative stroke after carotid endarterectomy. J Vasc Surg.
  248. (1992). The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis.
  249. (1996). The crystal structure of the complex of blood coagulation factor VIIa with human soluble tissue factor.
  250. (1996). The differing effects of regional and general anaesthesia on cerebral metabolism during carotid endarterectomy. Eur J Vasc Endovasc Surg.
  251. The diffuse intimal thickening of the human aorta with aging.
  252. The effect of heparin on platelets in vivo.
  253. The effect of molecular weight on heparin binding to platelets.
  254. The effectof commercial heparin on the platelet count.
  255. (1990). The global burden of disease,
  256. (1990). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in
  257. The influence of heparin and protamine sulfate on platelet ADP and platelet factor 4 release and the expression of glycoprotein IIb/IIIa.
  258. The mechanism of heparin-induced platelet aggregation.
  259. (2005). The molecular physiology and pathology of fibrin structure/function. Blood Reviews.
  260. (1983). The mononuclear phagocytic system: A review. Hum Pathol.
  261. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
  262. The platelet aggregating effect of eight commercial heparins.
  263. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcáR and the natural killer receptors.
  264. The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.
  265. The platelet release reaction: granules' constituents, secretion and functions.
  266. The practice of carotid endarterectomy in a large metropolitan area.
  267. The renal artery in normal and cholesterol-fed rabbits.
  268. The role of fibrinogen as a cardiovascular risk factor.
  269. The role of heparinassociated antiplatelet antibodies in the outcome of arterial reconstruction.
  270. (1990). The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J.
  271. (1979). The smooth muscle cell in culture. Physiol Rev.
  272. The structure and properties of the cell surface coat. Int Rev Cytol.
  273. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments.
  274. (1994). The use of duplex scanning to diagnose perioperative carotid occlusions. Eur J Vasc Surg.
  275. Thresholds in cerebral ischemia: the ischemic penumbra.
  276. (1999). Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol.
  277. (2003). Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet.
  278. Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions.
  279. (1992). Thrombosis and cardiovascular risk in the elderly. Arch Pathol Lab Med.
  280. (1989). Thromboxane A2: Its generation and role in platelet activation. Prog Lipid Res.
  281. Thromboxanes: A new group of biologically active compounds drived from prostaglandin endoperoxides.
  282. TIssue factor anf hemostasis.
  283. (1995). Tissue factor: Molecular recognition and cofactor function.
  284. Topol E, CHARISMA investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
  285. (1997). Transcranial Doppler detected cerebral microembolism following carotid endarterectomy. High microembolic signal loads predict postoperative cerebral ischaemia.
  286. (1997). Transcranial Doppler monitoring and causes of stroke from carotid endarterectomy.
  287. Transcranial Doppler-directed Dextran-40 therapy is a cost-effective method of preventing carotid thrombosis after carotid endarterectomy.
  288. (1998). Transcranial Doppler: preventing stroke during carotid endarterectomy.
  289. (1996). Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis.
  290. (1993). Two-year follow-up of aspirin responder and aspirin non-repsonder. A pilot-study including 180 post-stroke patients. Thromb Res.
  291. Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesis.
  292. Variation in carotid endarterectomy mortality in the Medicare population: Trial Hospitals, volume and patient characteristics.
  293. (2001). Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis. Crit Care Med.
  294. (2001). What caused this transient or persisting ischaemic event? In: Stroke: a practical guide to management.
  295. (2006). What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol.
  296. Why do plaques rupture?

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.